Tight Junction Regulation by Morphine and HIV-1 Tat Modulates Blood–Brain Barrier Permeability

被引:0
作者
Supriya D. Mahajan
Ravikumar Aalinkeel
Donald E. Sykes
Jessica L. Reynolds
B. Bindukumar
Stanley F. Fernandez
Ramnik Chawda
Thomas C. Shanahan
Stanley A. Schwartz
机构
[1] Buffalo General Hospital,Division of Allergy, Immunology, and Rheumatology, Department of Medicine
[2] School of Medicine and Biomedical Sciences,Department of Pharmacology
[3] Upstate New York Transplant Services,undefined
来源
Journal of Clinical Immunology | 2008年 / 28卷
关键词
Morphine; neuropathogenesis; HIV-1; HIV-1 associated dementia; blood–brain barrier; tight junctions; drug abuse;
D O I
暂无
中图分类号
学科分类号
摘要
Human immunodeficiency virus (HIV)-1 patients who abuse opiates are at a greater risk of developing neurological complications of AIDS. Alterations in blood–brain barrier (BBB) integrity are associated with cytoskeletal disorganization and disruption of tight junction (TJ) integrity. We hypothesize that opiates in combination with HIV-1 viral proteins can modulate TJ expression in primary brain microvascular endothelial cells (BMVEC), thereby compromising BBB integrity and exacerbating HIV-1 neuropathogenesis. We investigated the effect of morphine and/or tat on the expression of TJ proteins ZO-1, JAM-2, Occludin and P-glycoprotein and the functional effects of TJ modulation in BMVEC. Morphine and/or tat, via the activation of pro-inflammatory cytokines, intracellular Ca2+ release, and activation of myosin light chain kinase, modulated TJ expression resulting in decreased transendothelial electric resistance and enhanced transendothelial migration across the BBB. These studies may lead to the development of novel anti-HIV-1 therapeutics that target specific TJ proteins, thus preventing TJ disruption in opiate using HIV-1 patients.
引用
收藏
相关论文
共 290 条
  • [1] Ozdener H(2005)Molecular mechanisms of HIV-1 associated neurodegeneration J Biosci 30 391-405
  • [2] Trujillo JR(2005)International neuroAIDS: prospects of HIV-1 associated neurological complications Cell Res 15 962-9
  • [3] Jaramillo-Rangel G(1991)HIV-related neurotoxicity Brain Pathol 1 193-106
  • [4] Ortega-Martinez M(1996)Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain J Immunol 156 1284-96
  • [5] Penalva de Oliveira AC(1999)Interactions between macrophages and brain microvascular endothelial cells: role in pathogenesis of HIV-1 infection and blood–brain barrier function J Neurovirol 5 659-99
  • [6] Vidal JE(2002)Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia J Infect Dis 186 S193-88
  • [7] Bryant J(1997)The neuropathogenesis of the AIDS dementia complex AIDS 11 S35-7
  • [8] Lipton SA(1999)Microglial and astrocyte chemokines regulate monocyte migration through the blood–brain barrier in human immunodeficiency virus-1 encephalitis Am J Pathol 155 1599-34
  • [9] Nottet HS(2000)Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines J Neurovirol 6 382-87
  • [10] Persidsky Y(2000)HIV-1-associated central nervous system dysfunction Adv Pharmacol 49 315-80